Literature DB >> 18309672

[Cytokines mechanism of shenfu injection in treatment of cardiogenic shock in canine].

Da-Zhi Ke1, Qing-Wei Chen, Chun-Li Li, Gui-Qiong Li.   

Abstract

OBJECTIVE: To investigate the effect of shenfu injection on canine with cardiogenic shock and the possible mechanism.
METHOD: Cardiogenic shock model of canine was established by ligating left anterior descending (LAD) of coronary artery. The 15 canines with cardiogenic shock were randomly divided in to glucose injection group, shenfu injection group and sham-operated group. The hemodynamics parameters were monitored. Plasma TNF-alpha and IL-1beta levels were measured by radioimmunoassay. Expression of TNF-alpha mRNA and IL-1beta mRNA in myocardium were detected by RT-PCR. RESULT: Following cardiogenic shock, the mean artery pressure (MAP), left ventricular systolic pressure (LVSP), ventricular pressure rise ratio during systolic period (+ dp/dt(max)), and ventricular pressure decay ratio during diastolic period (- dp/dt(max)) decreased significantly; the plasma TNF-alpha and IL-1beta levels and the expression of TNF-a mRNA and IL-1beta mRNA in myocardium increased significantly. In shenfu injection group, MAP, LVSP and +/- dp/dt(max) increased significantly and plasma TNF-alpha and IL-1beta levels decreased significantly. In glucose injection group, MAP, LVSP, +/- dp/dt(max) and plasma TNF-alpha and IL-1beta levels had not changed significantly. The expression of TNF-alpha mRNA and IL-1beta mRNA in myocardium were significantly lower in shenfu injection group than those in glucose injection group.
CONCLUSION: Shenfu injection probably can decrease over-exprssion of TNF-alpha mRNA and IL-1beta mRNA on transcription platform. Shenfu injection counteract cardiogenic shock, relieve myocardium damage and improve hemodynamics through inhibiting overproduction of TNF-alpha and IL-1beta.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18309672

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

1.  Shenfu Injection suppresses inflammation by targeting haptoglobin and pentraxin 3 in rats with chronic ischemic heart failure.

Authors:  Si-Dao Zheng; Hong-Jin Wu; Shao-Ping Yu; Jian-Xun Ren; Wei-Wei Duo; Zeng-Chun Ma; Yue Gao; Sheng-Qi Wang; Yu-Na Liu
Journal:  Chin J Integr Med       Date:  2013-03-15       Impact factor: 1.978

2.  Effect of Shenfu injection on immune function of mice bearing Lewis lung sarcoma with chemotherapy.

Authors:  Yukun Luo; Kangning Wang; Qiang Li; Jinyi Lang
Journal:  Tumour Biol       Date:  2016-01-29

3.  Pharmacokinetic evaluation of Shenfu Injection in beagle dogs after intravenous drip administration.

Authors:  Yuqiao Zhang; Dali Tian; Yuyou Huang; Ling Li; Juan Mao; Juan Tian; Jinsong Ding
Journal:  Acta Pharm Sin B       Date:  2016-06-11       Impact factor: 11.413

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.